A recent study highlights the potential of psilocybin therapy, showing significant reductions in depressive symptoms for patients receiving a single controlled dose. The conversation explores the implications of this treatment model, including concerns about commercialization and the future of mental health care. The idea of integrating therapy with virtual reality and psychedelics sparks intriguing possibilities for the future of mental wellness.
